Linked Life Data

7451150

Source:http://linkedlifedata.com/resource/pubmed/id/7451150

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1981-3-24
pubmed:abstractText
Intermittent chloroquine medication was given to 15 patients with porphyria cutanea tarda. These are the advantages of the chloroquine treatment: The clinical signs of porphyria cutanea tarda and the liver-dysfunction are re-adjusted in short time. The equilibrium of porphyrin metabolism is restored by the transformation of the biochemical manifest porphyria cutanea tarda into a latent form.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0017-8470
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
437-40
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
[Treatment of porphyria cutanea tarda with intermittent chloroquine].
pubmed:publicationType
Journal Article, English Abstract